These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 2847001)
21. Can post-eradication laboratory containment of wild polioviruses be achieved? Dowdle WR; Gary HE; Sanders R; van Loon AM Bull World Health Organ; 2002; 80(4):311-6. PubMed ID: 12075368 [TBL] [Abstract][Full Text] [Related]
22. Does smallpox linger as risk to hospital personnel? Hosp Infect Control; 1978 Oct; 5(10):153-6. PubMed ID: 10313858 [No Abstract] [Full Text] [Related]
23. The biology and immunopathology of simian immunodeficiency virus infection. Fultz PN; Anderson DC Curr Opin Immunol; 1989-1990 Feb; 2(3):403-8. PubMed ID: 2561344 [No Abstract] [Full Text] [Related]
24. Seroconversion to simian immunodeficiency virus in two laboratory workers. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1992 Sep; 41(36):678-81. PubMed ID: 1513304 [TBL] [Abstract][Full Text] [Related]
26. AIDS--minimising the risk to health care workers. Qld Nurse; 1987; 6(7):13-4. PubMed ID: 3120243 [No Abstract] [Full Text] [Related]
27. Use of simian immunodeficiency virus for evaluation of AIDS vaccine strategies. Daniel MD; Desrosiers RC AIDS; 1989; 3 Suppl 1():S131-3. PubMed ID: 2558686 [No Abstract] [Full Text] [Related]
29. [Infectious risks in bacteriology laboratories]. Valent C; Cavigneaux A Arch Mal Prof; 1970 Sep; 31(9):491-5. PubMed ID: 5516411 [No Abstract] [Full Text] [Related]
30. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control (CDC) MMWR Morb Mortal Wkly Rep; 1986 Jun; 35(23):376-8, 383. PubMed ID: 3012309 [No Abstract] [Full Text] [Related]
31. Leads from the MMWR. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus. JAMA; 1986 Aug; 256(6):703-4. PubMed ID: 3014176 [No Abstract] [Full Text] [Related]
32. ABC of AIDS. Control of infection policies. Jeffries DJ Br Med J (Clin Res Ed); 1987 Jul; 295(6589):33-5. PubMed ID: 3113605 [No Abstract] [Full Text] [Related]
33. Vaccination against SIV infection and disease. Gardner MB AIDS Res Hum Retroviruses; 1990 Jul; 6(7):835-46. PubMed ID: 2167709 [No Abstract] [Full Text] [Related]
34. Suggested guidelines for work with live Trypanosoma cruzi. Trans R Soc Trop Med Hyg; 1983; 77(3):416-9. PubMed ID: 6414125 [No Abstract] [Full Text] [Related]
35. Reducing blood and body fluid exposures among clinical laboratory workers. Meeting the OSHA standards. Jagger J; Detmer DE; Cohen ML; Scarr PR; Pearson RD Clin Lab Manage Rev; 1992; 6(5):415-7, 420-4. PubMed ID: 10122816 [TBL] [Abstract][Full Text] [Related]
37. [Occupational biological risk and safety measures in medical laboratories]. Fernández Llanes R; de la Cruz Castillo F Rev Cubana Med Trop; 1986; 38(1):54-61. PubMed ID: 3550941 [No Abstract] [Full Text] [Related]
38. Inactivated simian immunodeficiency virus vaccine failed to protect rhesus macaques from intravenous or genital mucosal infection but delayed disease in intravenously exposed animals. Sutjipto S; Pedersen NC; Miller CJ; Gardner MB; Hanson CV; Gettie A; Jennings M; Higgins J; Marx PA J Virol; 1990 May; 64(5):2290-7. PubMed ID: 2157886 [TBL] [Abstract][Full Text] [Related]